Filed: 8/9/2024ACC: 0001104659-24-087771
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $1.92B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$1.92B
Total AUM (reported)
67.91M
Total Shares
Allocation by class
COM$1.30B67.7%
UNIT SER 1$191.64M10.0%
SPONSORED ADR$162.64M8.5%
CL A$101.09M5.3%
ADR$92.72M4.8%
SHS$30.14M1.6%
S&P BIOTECH$23.18M1.2%
Portfolio Concentration
Top 3$472.61M24.6%
4–10$540.55M28.1%
11–25$537.45M27.9%
Rest$373.56M19.4%
Top 3 weight
24.6%
Top 10 weight
52.7%
Voting Authority Distribution
Total shares with voting rights: 67.91M
Sole
Full voting authority
67.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
Invesco QQQ TR
SOLEShares400K
TypeSH
Market value$191.64M
9.96%
Sole
400K
Shared
0.00
None
0.00
Natera Inc
SOLEShares1.55M
TypeSH
Market value$167.88M
8.72%
Sole
1.55M
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares1.22M
TypeSH
Market value$113.08M
5.88%
Sole
1.22M
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares2.79M
TypeSH
Market value$101.09M
5.25%
Sole
2.79M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares734.28K
TypeSH
Market value$100.14M
5.20%
Sole
734.28K
Shared
0.00
None
0.00
Novo-Nordisk A S
SOLEShares649.54K
TypeSH
Market value$92.72M
4.82%
Sole
649.54K
Shared
0.00
None
0.00
Stryker Corporation
SOLEShares193.08K
TypeSH
Market value$65.70M
3.41%
Sole
193.08K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares801.42K
TypeSH
Market value$62.50M
3.25%
Sole
801.42K
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares137.22K
TypeSH
Market value$61.04M
3.17%
Sole
137.22K
Shared
0.00
None
0.00
Dyne Therapeutics Inc
SOLEShares1.63M
TypeSH
Market value$57.37M
2.98%
Sole
1.63M
Shared
0.00
None
0.00
Align Technology Inc
SOLEShares218.52K
TypeSH
Market value$52.76M
2.74%
Sole
218.52K
Shared
0.00
None
0.00
Alnylam Pharmaceuticals Inc
SOLEShares197.93K
TypeSH
Market value$48.10M
2.50%
Sole
197.93K
Shared
0.00
None
0.00
Rapport Therapeutics Inc
SOLEShares1.95M
TypeSH
Market value$45.39M
2.36%
Sole
1.95M
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares2.15M
TypeSH
Market value$44.21M
2.30%
Sole
2.15M
Shared
0.00
None
0.00
Elanco Animal Health Inc
SOLEShares2.86M
TypeSH
Market value$41.33M
2.15%
Sole
2.86M
Shared
0.00
None
0.00
Abbott Labs
SOLEShares390.20K
TypeSH
Market value$40.55M
2.11%
Sole
390.20K
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares1.15M
TypeSH
Market value$40.43M
2.10%
Sole
1.15M
Shared
0.00
None
0.00
TG Therapeutics Inc
SOLEShares1.86M
TypeSH
Market value$33.11M
1.72%
Sole
1.86M
Shared
0.00
None
0.00
Arrivent BioPharma Inc
SOLEShares1.70M
TypeSH
Market value$31.47M
1.64%
Sole
1.70M
Shared
0.00
None
0.00
IDEXX Labs Inc
SOLEShares63.86K
TypeSH
Market value$31.11M
1.62%
Sole
63.86K
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares195.85K
TypeSH
Market value$30.94M
1.61%
Sole
195.85K
Shared
0.00
None
0.00
Y-mAbs Therapeutics Inc
SOLEShares2.19M
TypeSH
Market value$26.51M
1.38%
Sole
2.19M
Shared
0.00
None
0.00
Axsome Therapeutics Inc
SOLEShares310.20K
TypeSH
Market value$24.97M
1.30%
Sole
310.20K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares2.77M
TypeSH
Market value$23.38M
1.22%
Sole
2.77M
Shared
0.00
None
0.00
Spdr Ser Tr
SOLEShares250K
TypeSH
Market value$23.18M
1.20%
Sole
250K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Invesco QQQ TRSOLE | UNIT SER 1 | 400K | SH | $191.64M 9.96% | 400K | 0.00 | 0.00 |
Natera IncSOLE | COM | 1.55M | SH | $167.88M 8.72% | 1.55M | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 1.22M | SH | $113.08M 5.88% | 1.22M | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 2.79M | SH | $101.09M 5.25% | 2.79M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 734.28K | SH | $100.14M 5.20% | 734.28K | 0.00 | 0.00 |
Novo-Nordisk A SSOLE | ADR | 649.54K | SH | $92.72M 4.82% | 649.54K | 0.00 | 0.00 |
Stryker CorporationSOLE | COM | 193.08K | SH | $65.70M 3.41% | 193.08K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 801.42K | SH | $62.50M 3.25% | 801.42K | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 137.22K | SH | $61.04M 3.17% | 137.22K | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | COM | 1.63M | SH | $57.37M 2.98% | 1.63M | 0.00 | 0.00 |
Align Technology IncSOLE | COM | 218.52K | SH | $52.76M 2.74% | 218.52K | 0.00 | 0.00 |
Alnylam Pharmaceuticals IncSOLE | COM | 197.93K | SH | $48.10M 2.50% | 197.93K | 0.00 | 0.00 |
Rapport Therapeutics IncSOLE | COM | 1.95M | SH | $45.39M 2.36% | 1.95M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 2.15M | SH | $44.21M 2.30% | 2.15M | 0.00 | 0.00 |
Elanco Animal Health IncSOLE | COM | 2.86M | SH | $41.33M 2.15% | 2.86M | 0.00 | 0.00 |
Abbott LabsSOLE | COM | 390.20K | SH | $40.55M 2.11% | 390.20K | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 1.15M | SH | $40.43M 2.10% | 1.15M | 0.00 | 0.00 |
TG Therapeutics IncSOLE | COM | 1.86M | SH | $33.11M 1.72% | 1.86M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | COM | 1.70M | SH | $31.47M 1.64% | 1.70M | 0.00 | 0.00 |
IDEXX Labs IncSOLE | COM | 63.86K | SH | $31.11M 1.62% | 63.86K | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 195.85K | SH | $30.94M 1.61% | 195.85K | 0.00 | 0.00 |
Y-mAbs Therapeutics IncSOLE | COM | 2.19M | SH | $26.51M 1.38% | 2.19M | 0.00 | 0.00 |
Axsome Therapeutics IncSOLE | COM | 310.20K | SH | $24.97M 1.30% | 310.20K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | COM | 2.77M | SH | $23.38M 1.22% | 2.77M | 0.00 | 0.00 |
Spdr Ser TrSOLE | S&P BIOTECH | 250K | SH | $23.18M 1.20% | 250K | 0.00 | 0.00 |
Page 1 of 3